A Primer on Radiopharmaceutical Therapy

This publication has 62 references indexed in Scilit:

• Novel Preclinical and Radiopharmaceutical Aspects of [⁶⁸Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
  Pharmaceuticals, 2014
• Synthesis of the first radiolabeled ¹⁸⁸Re N‐heterocyclic carbene complex and initial studies on its potential use in radiopharmaceutical applications
  Journal of Labelled Compounds and Radiopharmaceuticals, 2014
• Alpha Emitter Radium-223 and Survival in Metastatic Prostate Cancer
  New England Journal of Medicine, 2013
• Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas
  Journal of Clinical Oncology, 2005
• ¹³¹I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
  New England Journal of Medicine, 2005
• Samarium-153-Lexidronam complex for treatment of painful bone metastases in hormone-refractory prostate cancer
  Urology, 2004
• Treatment With Ibritumomab Tiuxetan Radioimmunotherapy in Patients With Rituximab-Refractory Follicular Non-Hodgkin’s Lymphoma
  Journal of Clinical Oncology, 2002
• Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma
  Journal of Clinical Oncology, 2002
• A prospective, randomised double-blind crossover study to examine the efficacy of strontium-89 in pain palliation in patients with advanced prostate cancer metastatic to bone
  European Journal of Cancer and Clinical Oncology, 1991
• CLINICAL STUDIES WITH THE AID OF RADIOACTIVE PHOSPHORUS. I. THE ABSORPTION AND DISTRIBUTION OF RADIO-PHOSPHORUS IN THE BLOOD AND ITS EXCRETION BY NORMAL INDIVIDUALS AND PATIENTS WITH LEUKEMIA 1
  Journal of Clinical Investigation, 1941